\-\ Texto\\:\\ \ \(0\)\
\-\ fever\\ with\\ erythema\\ and\\ edema\\ overlying\\ left\\ eyelid\ \(0\)\
\-\ admission\\ with\\ 50\\%\\ undergoing\\ subsequent\\ sinusotomy\\ of\\ the\\ abscess\\ using\\ a\\ nasal\\ approach\\ \\(\\+\\/\\-\\)\\ drain\\ which\\ should\\ be\\ left\\ in\\ place\\ for\\ one\\ week\\.\\ \\ once\\ cultures\\ are\\ obtained\\ from\\ the\\ fluid\\,\\ iv\\ antibiotics\\ should\\ be\\ instituted\\ immediately\\ in\\ order\\ to\\ prevent\\ meningitis\\ and\\ overwhelming\\ systemic\\ infection\\.\\ \\ first\\ choice\\ antibiotic\\ for\\ children\\ includes\\ cefuroxime\\ 100mg\\/kg\\ per\\ day\\ divided\\ into\\ three\\ or\\ four\\ doses\\ parenterally\\.\\ \\ antibiotics\\ should\\ be\\ continued\\ empirically\\ with\\ most\\ sources\\ recommending\\ a\\ minimum\\ of\\ 10\\ days\\.\\ \\ repeat\\ of\\ sinus\\ ct\\ with\\ contrast\\ should\\ be\\ repeated\\ post\\ surgically\\ as\\ well\\ as\\ after\\ discontinuation\\ of\\ antibiotics\\ to\\ ensure\\ resolution\\.\ \(0\)\
\-\ rim\\ enhancing\\ homogenous\\ soft\\ tissue\\ density\\ within\\ the\\ left\\ ethmoid\\ sinus\\ which\\ is\\ eroding\\ through\\ the\\ lamina\\ papyracea\\.\\ \\ subperiosteal\\ abscess\\ 1\\.4x\\ 0\\.8cm\\ displacing\\ the\\ medial\\ rectus\\ muscle\\.\\ \\ soft\\ tissue\\ edema\\ in\\ medial\\ periorbital\\ region\\ with\\ inflammatory\\ changes\\ within\\ the\\ fat\\ of\\ the\\ conus\\.\\ \\ mild\\ proptosis\\ of\\ the\\ left\\ eye\\.\ \(0\)\
\-\ ethmoiditis\\ with\\ subperiosteal\\ abscess\\ of\\ the\\ left\\ medial\\ orbit\ \(0\)\
\-\ left\\ ethmoidal\\ sinusitis\\ with\\ abscess\\,\\ mucocele\\,\\ orbital\\ dermoid\\ cyst\\,\\ primary\\ conjunctival\\ cyst\\,\\ sweat\\ gland\\ cyst\\,\\ lacrimal\\ gland\\ cyst\\,\\ lymphangioma\\,\\ idiopathic\\ orbital\\ inflammation\\,\\ and\\ orbital\\ granulomatous\\ inflammations\ \(0\)\
\-\ 20\\ month\\ old\\ boy\\ with\\ recurrent\\ orbital\\ redness\\ and\\ bulging\\ eye\\.\ \(1\)\
\-\ abscesses\\ and\\ orbital\\ cellulitis\\ are\\ characterized\\ by\\ massive\\ accumulation\\ of\\ pmns\\.\\ \\ causative\\ agent\\ can\\ usually\\ be\\ demonstrated\\ with\\ staining\\ following\\ aspiration\\ or\\ surgical\\ drainage\\.\\ \\ these\\ usually\\ occur\\ in\\ conjunction\\ with\\ adjacent\\ sinusitis\\ but\\ may\\ also\\ occur\\ after\\ orbital\\ trauma\\ or\\ with\\ systemic\\ infections\\.\\ \\ offending\\ pathogens\\ include\\ a\\ variety\\ of\\ bacterial\\,\\ viral\\,\\ fungal\\,\\ and\\ parasitic\\ etiologies\\,\\ however\\,\\ most\\ cases\\ arise\\ from\\ bacterial\\ infections\\ of\\ the\\ sinuses\\.\\ \\ these\\ bacterial\\ pathogens\\ in\\ children\\ include\\ those\\ of\\ typical\\ uri\\ etiologies\\ such\\ as\\ s\\.\\ pneumoniae\\,\\ h\\.\\ influenza\\ and\\ s\\.\\ aureus\\.\\ \\ pseudomonas\\ and\\ e\\.\\ coli\\ are\\ also\\ less\\ common\\ causes\\ of\\ orbital\\ cellulitis\\.\\ \\ \ \(0\)\
\-\ patients\\ typically\\ present\\ with\\ the\\ sudden\\ onset\\ of\\ pain\\,\\ eyelid\\ edema\\,\\ conjunctival\\ hyperemia\\ and\\ chemosis\\ and\\ sometimes\\ proptosis\\,\\ diplopia\\,\\ increased\\ iop\\,\\ and\\ blepharoptosis\\.\\ \\ orbital\\ cellulitis\\ is\\ one\\ of\\ the\\ most\\ common\\ causes\\ of\\ proptosis\\ in\\ children\\ less\\ than\\ five\\.\\ \\ patients\\ may\\ also\\ experience\\ fever\\,\\ malaise\\,\\ and\\ leukocytosis\\ with\\ signs\\ of\\ sinusitis\\.\ \(0\)\
\-\ subperiosteal\\ abscess\\ is\\ a\\ purulent\\ foci\\ within\\ the\\ adjacent\\ subperiosteal\\ space\\ that\\ can\\ lead\\ to\\ abaxial\\ displacement\\,\\ local\\ tenderness\\,\\ and\\ a\\ possible\\ fluctuant\\ mass\\.\\ \\ abscess\\ formation\\ may\\ be\\ rapid\\ with\\ destruction\\ of\\ tissue\\ planes\\ depending\\ on\\ the\\ severity\\ of\\ the\\ offending\\ pathogen\\.\\ \\ clinical\\ clues\\ may\\ include\\ profound\\ proptosis\\ with\\ a\\ functional\\ deficit\\ in\\ the\\ absence\\ of\\ striking\\ concomitant\\ inflammatory\\ signs\\ such\\ as\\ chemosis\\ and\\ lid\\ injection\\.\\ \\ \ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ typical\\ ct\\ features\\ of\\ a\\ subperiosteal\\ abscess\\ include\\ \\(\\+\\/\\-\\)\\ an\\ enhancing\\ capsule\\ with\\ smooth\\ contoured\\ periorbital\\ lesion\\ adjacent\\ to\\ an\\ opacified\\ sinus\\.\\ \\ cellulitis\\ would\\ appear\\ as\\ lid\\ edema\\,\\ sinus\\ opafication\\ with\\ mucosal\\ thickening\\.\\ \\ following\\ contrast\\ infusion\\,\\ periosteum\\ may\\ be\\ seen\\ to\\ enhance\\ therefore\\ giving\\ rise\\ to\\ an\\ enhancing\\ capsule\\ as\\ seen\\ in\\ this\\ patient\\.\ \(0\)\
\-\ complications\\ include\\ severe\\ septicemia\\ with\\ resultant\\ meningitis\\ and\\ cavernous\\ sinus\\ thrombosis\\;\\ however\\,\\ with\\ the\\ institution\\ of\\ immediate\\ incision\\ and\\ drainage\\ with\\ appropriate\\ iv\\ antibiotics\\ fatal\\ outcomes\\ have\\ dropped\\ dramatically\\ in\\ the\\ past\\ decade\\.\ \(0\)\
\-\ cavernous\\ sinus\\ thrombosis\\ would\\ present\\ with\\ headache\\,\\ nausea\\,\\ vomiting\\,\\ fever\\,\\ and\\ varying\\ levels\\ of\\ consciousness\\ in\\ addition\\ to\\ the\\ typical\\ signs\\ and\\ symptoms\\ of\\ orbital\\ cellulitis\\.\ \(0\)\
\-\ patients\\ should\\ be\\ monitored\\ while\\ hospitalized\\ for\\ worsening\\ symptoms\\ despite\\ antibiotic\\ treatment\\ in\\ order\\ to\\ prevent\\ these\\ fatal\\ outcomes\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ orbital\\:\\ 0\\.29446242662543054\ \(0\)\
\-\ subperiosteal\\:\\ 0\\.21986344540400735\ \(0\)\
\-\ cellulitis\\:\\ 0\\.1957474448660035\ \(0\)\
\-\ of\\:\\ 0\\.16789240604264405\ \(0\)\
\-\ abscess\\:\\ 0\\.16766489592963113\ \(0\)\
\-\ sinus\\:\\ 0\\.16172134740875668\ \(0\)\
\-\ with\\:\\ 0\\.15338465895740033\ \(0\)\
\-\ proptosis\\:\\ 0\\.15053490181564916\ \(0\)\
\-\ the\\:\\ 0\\.14141568696858522\ \(0\)\
\-\ and\\:\\ 0\\.1387408651187875\ \(0\)\
\-\ should\\:\\ 0\\.12169498806152958\ \(0\)\
\-\ be\\:\\ 0\\.12105268062815083\ \(0\)\
\-\ sinusitis\\:\\ 0\\.11542428471077174\ \(0\)\
\-\ include\\:\\ 0\\.11096922132042364\ \(0\)\
\-\ antibiotics\\:\\ 0\\.10992252843264802\ \(0\)\
\-\ bacterial\\:\\ 0\\.10472290173685565\ \(0\)\
\-\ pathogens\\:\\ 0\\.10292154455871794\ \(0\)\
\-\ in\\:\\ 0\\.10207246924797067\ \(0\)\
\-\ conjunctival\\:\\ 0\\.09701043333011919\ \(0\)\
\-\ offending\\:\\ 0\\.09701043333011919\ \(0\)\
\-\ chemosis\\:\\ 0\\.09587248895867649\ \(0\)\
\-\ may\\:\\ 0\\.09385557271564408\ \(0\)\
\-\ lid\\:\\ 0\\.09211015113071075\ \(0\)\
\-\ children\\:\\ 0\\.09169069428812711\ \(0\)\
\-\ eyelid\\:\\ 0\\.09131729564958126\ \(0\)\
\-\ as\\:\\ 0\\.0899111731906167\ \(0\)\
\-\ outcomes\\:\\ 0\\.08919185519026147\ \(0\)\
\-\ edema\\:\\ 0\\.08898889840758194\ \(0\)\
\-\ fatal\\:\\ 0\\.08736403311491765\ \(0\)\
\-\ periorbital\\:\\ 0\\.08680743379016025\ \(0\)\
\-\ typical\\:\\ 0\\.08648217577188792\ \(0\)\
\-\ cyst\\:\\ 0\\.08607063058457248\ \(0\)\
\-\ signs\\:\\ 0\\.07820816855260043\ \(0\)\
\-\ left\\:\\ 0\\.07634541351921346\ \(0\)\
\-\ fever\\:\\ 0\\.07587197267628339\ \(0\)\
\-\ etiologies\\:\\ 0\\.07482408268119471\ \(0\)\
\-\ to\\:\\ 0\\.0746017125641686\ \(0\)\
\-\ capsule\\:\\ 0\\.07299626060585089\ \(0\)\
\-\ medial\\:\\ 0\\.07284065758035549\ \(0\)\
\-\ adjacent\\:\\ 0\\.07253583422984991\ \(0\)\
\-\ meningitis\\:\\ 0\\.07026888937209946\ \(0\)\
\-\ enhancing\\:\\ 0\\.07010083265908343\ \(0\)\
\-\ antibiotic\\:\\ 0\\.06981526782457043\ \(0\)\
\-\ order\\:\\ 0\\.06895266225737638\ \(0\)\
\-\ prevent\\:\\ 0\\.06840766214414386\ \(0\)\
\-\ systemic\\:\\ 0\\.06620239573930833\ \(0\)\
\-\ infections\\:\\ 0\\.06586846840352342\ \(0\)\
\-\ cavernous\\:\\ 0\\.06471222016606\ \(0\)\
\-\ these\\:\\ 0\\.06319185943384711\ \(0\)\
\-\ patients\\:\\ 0\\.06295180954953357\ \(0\)\
\-\ thrombosis\\:\\ 0\\.06082473200375438\ \(0\)\
\-\ gland\\:\\ 0\\.06060243582794408\ \(0\)\
\-\ drainage\\:\\ 0\\.059749213097553565\ \(0\)\
\-\ eye\\:\\ 0\\.059680561443126244\ \(0\)\
\-\ sinusotomy\\:\\ 0\\.05965265831812975\ \(0\)\
\-\ parenterally\\:\\ 0\\.05965265831812975\ \(0\)\
\-\ recommending\\:\\ 0\\.05965265831812975\ \(0\)\
\-\ ethmoiditis\\:\\ 0\\.05965265831812975\ \(0\)\
\-\ blepharoptosis\\:\\ 0\\.05965265831812975\ \(0\)\
\-\ abaxial\\:\\ 0\\.05965265831812975\ \(0\)\
\-\ opafication\\:\\ 0\\.05965265831812975\ \(0\)\
\-\ tissue\\:\\ 0\\.05870202660048324\ \(0\)\
\-\ most\\:\\ 0\\.05823794298521888\ \(0\)\
\-\ inflammations\\:\\ 0\\.057001299647854504\ \(0\)\
\-\ causes\\:\\ 0\\.056371039637134975\ \(0\)\
\-\ cefuroxime\\:\\ 0\\.055120130733871626\ \(0\)\
\-\ discontinuation\\:\\ 0\\.055120130733871626\ \(0\)\
\-\ septicemia\\:\\ 0\\.055120130733871626\ \(0\)\
\-\ occur\\:\\ 0\\.05486615026881838\ \(0\)\
\-\ iv\\:\\ 0\\.053304727935705044\ \(0\)\
\-\ would\\:\\ 0\\.05280959838835709\ \(0\)\
\-\ also\\:\\ 0\\.05263617490838937\ \(0\)\
\-\ pseudomonas\\:\\ 0\\.052468772063596375\ \(0\)\
\-\ pathogen\\:\\ 0\\.052468772063596375\ \(0\)\
\-\ within\\:\\ 0\\.051539277489947376\ \(0\)\
\-\ overwhelming\\:\\ 0\\.05146077227935897\ \(0\)\
\-\ minimum\\:\\ 0\\.05146077227935897\ \(0\)\
\-\ papyracea\\:\\ 0\\.05146077227935897\ \(0\)\
\-\ clues\\:\\ 0\\.05146077227935897\ \(0\)\
\-\ less\\:\\ 0\\.0507531718630014\ \(0\)\
\-\ eroding\\:\\ 0\\.050587603149613504\ \(0\)\
\-\ iop\\:\\ 0\\.050587603149613504\ \(0\)\
\-\ fluctuant\\:\\ 0\\.050587603149613504\ \(0\)\
\-\ contoured\\:\\ 0\\.050587603149613504\ \(0\)\
\-\ inflammatory\\:\\ 0\\.05044543742629241\ \(0\)\
\-\ empirically\\:\\ 0\\.04981741339332112\ \(0\)\
\-\ pmns\\:\\ 0\\.04981741339332112\ \(0\)\
\-\ dramatically\\:\\ 0\\.04981741339332112\ \(0\)\
\-\ ethmoidal\\:\\ 0\\.048505216665059595\ \(0\)\
\-\ influenza\\:\\ 0\\.048505216665059595\ \(0\)\
\-\ such\\:\\ 0\\.04798800083469641\ \(0\)\
\-\ instituted\\:\\ 0\\.047936244479338246\ \(0\)\
\-\ pneumoniae\\:\\ 0\\.047936244479338246\ \(0\)\
\-\ dropped\\:\\ 0\\.04741284080602901\ \(0\)\
\-\ usually\\:\\ 0\\.04696491111250056\ \(0\)\
\-\ sweat\\:\\ 0\\.046928244695100846\ \(0\)\
\-\ causative\\:\\ 0\\.046928244695100846\ \(0\)\
\-\ doses\\:\\ 0\\.046055075565355375\ \(0\)\
\-\ lamina\\:\\ 0\\.046055075565355375\ \(0\)\
\-\ profound\\:\\ 0\\.046055075565355375\ \(0\)\
\-\ uri\\:\\ 0\\.04565864782479063\ \(0\)\
\-\ following\\:\\ 0\\.04475428775368367\ \(0\)\
\-\ sources\\:\\ 0\\.04459592759513074\ \(0\)\
\-\ opacified\\:\\ 0\\.04459592759513074\ \(0\)\
\-\ hospitalized\\:\\ 0\\.04459592759513074\ \(0\)\
\-\ lacrimal\\:\\ 0\\.04427688602482559\ \(0\)\
\-\ conjunction\\:\\ 0\\.04427688602482559\ \(0\)\
\-\ coli\\:\\ 0\\.04427688602482559\ \(0\)\
\-\ striking\\:\\ 0\\.04427688602482559\ \(0\)\
\-\ however\\:\\ 0\\.044155838440775835\ \(0\)\
\-\ periosteum\\:\\ 0\\.043972689080801465\ \(0\)\
\-\ hyperemia\\:\\ 0\\.043682016557458826\ \(0\)\
\-\ displacing\\:\\ 0\\.04340371689508012\ \(0\)\
\-\ staining\\:\\ 0\\.04340371689508012\ \(0\)\
\-\ redness\\:\\ 0\\.043136779624906106\ \(0\)\
\-\ aureus\\:\\ 0\\.043136779624906106\ \(0\)\
\-\ purulent\\:\\ 0\\.04288031322177089\ \(0\)\
\-\ infusion\\:\\ 0\\.04288031322177089\ \(0\)\
\-\ giving\\:\\ 0\\.04288031322177089\ \(0\)\
\-\ an\\:\\ 0\\.04279150292130534\ \(0\)\
\-\ one\\:\\ 0\\.04271331803893682\ \(0\)\
\-\ are\\:\\ 0\\.04246226921323214\ \(0\)\
\-\ concomitant\\:\\ 0\\.042395717110842716\ \(0\)\
\-\ rise\\:\\ 0\\.042395717110842716\ \(0\)\
\-\ common\\:\\ 0\\.04230804839548906\ \(0\)\
\-\ lymphangioma\\:\\ 0\\.04216625303817042\ \(0\)\
\-\ mucocele\\:\\ 0\\.04173015446772954\ \(0\)\
\-\ agent\\:\\ 0\\.04173015446772954\ \(0\)\
\-\ incision\\:\\ 0\\.04173015446772954\ \(0\)\
\-\ divided\\:\\ 0\\.04152254798109725\ \(0\)\
\-\ malaise\\:\\ 0\\.041321330410526214\ \(0\)\
\-\ symptoms\\:\\ 0\\.040818151884433586\ \(0\)\
\-\ leukocytosis\\:\\ 0\\.04075235822480487\ \(0\)\
\-\ parasitic\\:\\ 0\\.04057319482376833\ \(0\)\
\-\ conus\\:\\ 0\\.040063400010872614\ \(0\)\
\-\ monitored\\:\\ 0\\.040063400010872614\ \(0\)\
\-\ soft\\:\\ 0\\.039716676317794616\ \(0\)\
\-\ homogenous\\:\\ 0\\.03959049122221297\ \(0\)\
\-\ bulging\\:\\ 0\\.03959049122221297\ \(0\)\
\-\ variety\\:\\ 0\\.03944016149654334\ \(0\)\
\-\ decade\\:\\ 0\\.03929321025458023\ \(0\)\
\-\ resultant\\:\\ 0\\.039149488973200704\ \(0\)\
\-\ varying\\:\\ 0\\.039149488973200704\ \(0\)\
\-\ can\\:\\ 0\\.03914892295386471\ \(0\)\
\-\ ethmoid\\:\\ 0\\.03900885871294632\ \(0\)\
\-\ diplopia\\:\\ 0\\.03900885871294632\ \(0\)\
\-\ or\\:\\ 0\\.03892921699658173\ \(0\)\
\-\ ensure\\:\\ 0\\.038871189310821994\ \(0\)\
\-\ repeated\\:\\ 0\\.03873635865633006\ \(0\)\
\-\ rectus\\:\\ 0\\.03860425204064798\ \(0\)\
\-\ planes\\:\\ 0\\.03847476157025724\ \(0\)\
\-\ massive\\:\\ 0\\.03834778563751276\ \(0\)\
\-\ present\\:\\ 0\\.03828086249185248\ \(0\)\
\-\ abscesses\\:\\ 0\\.03786318952658459\ \(0\)\
\-\ drain\\:\\ 0\\.03719762688347141\ \(0\)\
\-\ experience\\:\\ 0\\.037092999770292207\ \(0\)\
\-\ institution\\:\\ 0\\.03688863766728812\ \(0\)\
\-\ severity\\:\\ 0\\.036788802826268084\ \(0\)\
\-\ functional\\:\\ 0\\.03659359265627437\ \(0\)\
\-\ contrast\\:\\ 0\\.03624773376554324\ \(0\)\
\-\ after\\:\\ 0\\.03619079806335408\ \(0\)\
\-\ accumulation\\:\\ 0\\.03604066723951021\ \(0\)\
\-\ approach\\:\\ 0\\.035780803042030684\ \(0\)\
\-\ immediate\\:\\ 0\\.03569642696723751\ \(0\)\
\-\ depending\\:\\ 0\\.035530872426614485\ \(0\)\
\-\ choice\\:\\ 0\\.03536940607310087\ \(0\)\
\-\ deficit\\:\\ 0\\.03529014382907471\ \(0\)\
\-\ cultures\\:\\ 0\\.03513444468604973\ \(0\)\
\-\ sinuses\\:\\ 0\\.03513444468604973\ \(0\)\
\-\ mucosal\\:\\ 0\\.03513444468604973\ \(0\)\
\-\ seen\\:\\ 0\\.03512215820167058\ \(0\)\
\-\ once\\:\\ 0\\.03505796363795484\ \(0\)\
\-\ sometimes\\:\\ 0\\.03490763391228521\ \(0\)\
\-\ consciousness\\:\\ 0\\.034833745498230165\ \(0\)\
\-\ rapid\\:\\ 0\\.0346884271830001\ \(0\)\
\-\ surgically\\:\\ 0\\.034616961388942574\ \(0\)\
\-\ orbit\\:\\ 0\\.03454626821319615\ \(0\)\
\-\ viral\\:\\ 0\\.03440713413303491\ \(0\)\
\-\ characterized\\:\\ 0\\.03427089889147528\ \(0\)\
\-\ immediately\\:\\ 0\\.03413744415599283\ \(0\)\
\-\ arise\\:\\ 0\\.03413744415599283\ \(0\)\
\-\ nasal\\:\\ 0\\.03400665869499117\ \(0\)\
\-\ destruction\\:\\ 0\\.03400665869499117\ \(0\)\
\-\ which\\:\\ 0\\.03392240749029756\ \(0\)\
\-\ for\\:\\ 0\\.03391707629424496\ \(0\)\
\-\ undergoing\\:\\ 0\\.03387843782077344\ \(0\)\
\-\ erythema\\:\\ 0\\.0337526828860847\ \(0\)\
\-\ five\\:\\ 0\\.03369070085738571\ \(0\)\
\-\ place\\:\\ 0\\.03362930082815918\ \(0\)\
\-\ fungal\\:\\ 0\\.03338930856923495\ \(0\)\
\-\ enhance\\:\\ 0\\.03338930856923495\ \(0\)\
\-\ lead\\:\\ 0\\.033214923432984295\ \(0\)\
\-\ granulomatous\\:\\ 0\\.03315781341871794\ \(0\)\
\-\ therefore\\:\\ 0\\.03287951375633923\ \(0\)\
\-\ appropriate\\:\\ 0\\.03277142774063638\ \(0\)\
\-\ repeat\\:\\ 0\\.03271804740282561\ \(0\)\
\-\ aspiration\\:\\ 0\\.03261257648616521\ \(0\)\
\-\ injection\\:\\ 0\\.032457492812581\ \(0\)\
\-\ despite\\:\\ 0\\.032457492812581\ \(0\)\
\-\ sudden\\:\\ 0\\.03225627524200996\ \(0\)\
\-\ local\\:\\ 0\\.03210932400004685\ \(0\)\
\-\ those\\:\\ 0\\.03191838911956045\ \(0\)\
\-\ overlying\\:\\ 0\\.03177875986276283\ \(0\)\
\-\ idiopathic\\:\\ 0\\.03155247240179668\ \(0\)\
\-\ dermoid\\:\\ 0\\.03150813965525208\ \(0\)\
\-\ admission\\:\\ 0\\.03112211614133491\ \(0\)\
\-\ per\\:\\ 0\\.03095760293442991\ \(0\)\
\-\ smooth\\:\\ 0\\.030797127271785327\ \(0\)\
\-\ using\\:\\ 0\\.030679303272051206\ \(0\)\
\-\ is\\:\\ 0\\.030645519533445156\ \(0\)\
\-\ continued\\:\\ 0\\.030563564762709036\ \(0\)\
\-\ foci\\:\\ 0\\.030487528381920325\ \(0\)\
\-\ displacement\\:\\ 0\\.03041236600187719\ \(0\)\
\-\ resolution\\:\\ 0\\.030264584456431466\ \(0\)\
\-\ four\\:\\ 0\\.030228155086063975\ \(0\)\
\-\ addition\\:\\ 0\\.0301919275414984\ \(0\)\
\-\ features\\:\\ 0\\.030013740628938027\ \(0\)\
\-\ inflammation\\:\\ 0\\.029978678587462337\ \(0\)\
\-\ recurrent\\:\\ 0\\.02990911351575883\ \(0\)\
\-\ absence\\:\\ 0\\.02973837130721715\ \(0\)\
\-\ rim\\:\\ 0\\.02970475141275474\ \(0\)\
\-\ from\\:\\ 0\\.029628870246431224\ \(0\)\
\-\ formation\\:\\ 0\\.029571974159149046\ \(0\)\
\-\ levels\\:\\ 0\\.029571974159149046\ \(0\)\
\-\ appear\\:\\ 0\\.029377730518618108\ \(0\)\
\-\ includes\\:\\ 0\\.029005740844700624\ \(0\)\
\-\ nausea\\:\\ 0\\.02865377849421769\ \(0\)\
\-\ complications\\:\\ 0\\.028568670285396044\ \(0\)\
\-\ worsening\\:\\ 0\\.028484655574205427\ \(0\)\
\-\ ct\\:\\ 0\\.028401795552658555\ \(0\)\
\-\ subsequent\\:\\ 0\\.028238900156378248\ \(0\)\
\-\ vomiting\\:\\ 0\\.02760106009879872\ \(0\)\
\-\ muscle\\:\\ 0\\.026486283800842135\ \(0\)\
\-\ obtained\\:\\ 0\\.026384585715738106\ \(0\)\
\-\ typically\\:\\ 0\\.02618581493848598\ \(0\)\
\-\ 50\\:\\ 0\\.026050185230401247\ \(0\)\
\-\ headache\\:\\ 0\\.025713816818314476\ \(0\)\
\-\ boy\\:\\ 0\\.02551646410076932\ \(0\)\
\-\ thickening\\:\\ 0\\.0253765859315007\ \(0\)\
\-\ possible\\:\\ 0\\.025273606558047616\ \(0\)\
\-\ first\\:\\ 0\\.02517222382849662\ \(0\)\
\-\ week\\:\\ 0\\.025088922637418944\ \(0\)\
\-\ cases\\:\\ 0\\.025088922637418944\ \(0\)\
\-\ three\\:\\ 0\\.02503944657489092\ \(0\)\
\-\ space\\:\\ 0\\.02482927343788675\ \(0\)\
\-\ density\\:\\ 0\\.024734502865027066\ \(0\)\
\-\ past\\:\\ 0\\.02428021919345183\ \(0\)\
\-\ while\\:\\ 0\\.024106989061190482\ \(0\)\
\-\ 20\\:\\ 0\\.024064389203239174\ \(0\)\
\-\ onset\\:\\ 0\\.023952127989947305\ \(0\)\
\-\ day\\:\\ 0\\.02376019225921505\ \(0\)\
\-\ clinical\\:\\ 0\\.023639714960573162\ \(0\)\
\-\ days\\:\\ 0\\.023613241017251943\ \(0\)\
\-\ severe\\:\\ 0\\.023613241017251943\ \(0\)\
\-\ tenderness\\:\\ 0\\.023392437644064745\ \(0\)\
\-\ fat\\:\\ 0\\.023203616390132277\ \(0\)\
\-\ primary\\:\\ 0\\.02293618281582774\ \(0\)\
\-\ demonstrated\\:\\ 0\\.022924282803319686\ \(0\)\
\-\ month\\:\\ 0\\.0226907202942434\ \(0\)\
\-\ changes\\:\\ 0\\.022543259204315547\ \(0\)\
\-\ infection\\:\\ 0\\.022532052594771437\ \(0\)\
\-\ region\\:\\ 0\\.02231186158685596\ \(0\)\
\-\ through\\:\\ 0\\.02220448552773254\ \(0\)\
\-\ 10\\:\\ 0\\.021811817665604964\ \(0\)\
\-\ trauma\\:\\ 0\\.021663083693241363\ \(0\)\
\-\ fluid\\:\\ 0\\.021536861933275354\ \(0\)\
\-\ mild\\:\\ 0\\.021144961056905588\ \(0\)\
\-\ than\\:\\ 0\\.021144961056905588\ \(0\)\
\-\ post\\:\\ 0\\.020296745853628624\ \(0\)\
\-\ increased\\:\\ 0\\.02017068787625429\ \(0\)\
\-\ into\\:\\ 0\\.01982864886808371\ \(0\)\
\-\ have\\:\\ 0\\.018633970134386692\ \(0\)\
\-\ but\\:\\ 0\\.01844547664911757\ \(0\)\
\-\ surgical\\:\\ 0\\.0181295753554768\ \(0\)\
\-\ well\\:\\ 0\\.018061400401871302\ \(0\)\
\-\ lesion\\:\\ 0\\.017883000793141535\ \(0\)\
\-\ treatment\\:\\ 0\\.017768516704732288\ \(0\)\
\-\ that\\:\\ 0\\.016187299973138922\ \(0\)\
\-\ by\\:\\ 0\\.015840231389806347\ \(0\)\
\-\ mass\\:\\ 0\\.01424804329467415\ \(0\)\
\-\ pain\\:\\ 0\\.013347723974002254\ \(0\)\
\-\ this\\:\\ 0\\.012817346660422444\ \(0\)\
\-\ patient\\:\\ 0\\.012132191328288853\ \(0\)\
\-\ on\\:\\ 0\\.011265587372134372\ \(0\)\
\-\ old\\:\\ 0\\.011039639902946404\ \(0\)\
